Long-term results of RTOG 91-11: A comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer

Journal of Clinical Oncology

Volumn 31, Issue 7, 2013, Pages 845-852

  Forastiere, Arlene A ^a   Zhang, Qiang ^b   Weber, Randal S ^e   Maor, Moshe H ^e   Goepfert, Helmuth ^e   Pajak, Thomas F ^b   Morrison, William ^e   Glisson, Bonnie ^e   Trotti, Andy ^f   Ridge, John A ^c   Thorstad, Wade ^g   Wagner, Henry ^d   Ensley, John F ^h   Cooper, Jay S ⁱ  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Radiation Therapy Oncology Group Statistical Center   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g WASHINGTON UNIVERSITY   (United States)

^h Harper Grace Hospital   (United States)

ⁱ Maimonides Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LARYNGECTOMY; LARYNX; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SPEECH; SWALLOWING; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DEGLUTITION; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LARYNX; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGAN SPARING TREATMENTS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SALVAGE THERAPY; SPEECH; TREATMENT OUTCOME;

EID: 84875736113     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.6097     Document Type: Article

References (17)

1. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098, 2003. (Pubitemid 37464533)
2. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324:1685-1690, 1991.
3. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958.
4. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966.
5. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988.
6. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972.
7. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: Analysis and examples. Br J Cancer 35:1-39, 1977. (Pubitemid 8018922)
8. Forastiere AA, Trotti AM: Searching for less toxic larynx preservation: A need for common definitions and metrics. J Natl Cancer Inst 101:129-131, 2009.
9. List MA, Stracks J, Colangelo L, et al: How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol 18:877-884, 2000. (Pubitemid 30106620)
10. Pignon JP, le MaÎtre A, Maillard E, et al: Metaanalysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17, 346 patients. Radiother Oncol 92:4-14, 2009.
11. Lefebvre JL, Rolland F, Tesselaar M, et al: Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 101:142-152, 2009.
12. Lorch JH, Goloubeva O, Haddad RI, et al: Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: Long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol 12:153-159, 2011.
13. Pointreau Y, Garaud P, Chapet S, et al: Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498-506, 2009.
14. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567-578, 2006. (Pubitemid 43209104)
15. Ang K: A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC). J Clin Oncol s29:360s, 2011 (suppl; abstr 5500).
16. Holsinger FC, Kies MS, Diaz EM Jr, et al: Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol 27:1976-1982, 2009.
17. Forastiere AA, Shaha AR: Chemotherapy alone for laryngeal preservation: Is it possible? J Clin Oncol 27:1933-1934, 2009.